Skip to main content
. 2019 Nov 7;45(11):271–282. doi: 10.14745/ccdr.v45i11a01

Table 2. Experiences of discrimination related to knowledge or presumption of attraction to men, mental health and substance use of Canadian participants in the EMIS-2017 (N=5,165).

Characteristics British Columbia + Yukon
(n=1,191)a
Alberta + Northwest Territories
(n=710)a
Saskatchewan + Manitoba
(n=339)a
Ontario + Nunavut
(n=1,707)a
Quebec
(n=789)a
Atlantic Provinces
(n=429)a
Total
(N=5,165)a
n % n % n % n % n % n % n %
Homophobic intimidation and assault started at or intimidatedb
Within last six months 172 14.5 94 13.3 43 12.7 233 13.7 67 8.5 38 8.9 647 12.6
Six months to a year ago 249 20.9 145 20.5 69 20.4 306 18.0 135 17.2 89 20.7 993 19.3
1–5 years ago 190 16.0 96 13.5 36 10.6 240 14.1 115 14.6 60 14.0 737 14.3
5+ years ago 257 21.6 104 14.7 49 14.5 351 20.6 184 23.4 80 18.6 1,025 19.9
Never 321 27.0 270 38.1 142 41.9 570 33.5 286 36.3 162 37.8 1,751 34.0
Verbal insultsb
Within last six months 77 6.5 57 8.1 19 5.6 98 5.8 35 4.5 18 4.2 304 5.9
Six months to a year ago 223 18.8 113 16.0 62 18.3 289 17.0 83 10.6 64 15.0 834 16.2
1–5 years ago 265 22.3 117 16.5 60 17.7 332 19.5 149 19.0 73 17.1 996 19.4
5+ years ago 323 27.2 137 19.4 70 20.6 460 27.1 219 27.9 122 28.5 1,331 25.9
Never 301 25.3 283 40.0 128 37.8 520 30.6 299 38.1 151 35.3 1,682 32.7
Punched, hit, kicked or beatenb
Within last six months 4 0.3 8 1.1 1 0.3 4 0.2 1 0.1 4 0.9 22 0.4
Six months to a year ago 17 1.4 10 1.4 5 1.5 11 0.6 7 0.9 6 1.4 56 1.1
1–5 years ago 40 3.4 40 5.6 13 3.8 50 2.9 23 2.9 13 3.0 179 3.5
5+ years ago 216 18.2 83 11.7 34 10.0 292 17.2 125 15.9 71 16.6 821 15.9
Never 913 76.7 568 80.1 286 84.4 1,342 79.0 630 80.2 334 78.0 4,073 79.1
Anxiety and Depression Scalec
Normal 472 40.0 276 39.1 137 40.7 731 43.4 321 41.3 188 44.7 2,125 41.6
Mild 393 33.3 249 35.3 116 34.4 546 32.4 308 39.6 149 35.4 1,761 34.5
Moderate 176 14.9 92 13.0 41 12.2 245 14.5 87 11.2 44 10.5 685 13.4
Severe 139 11.8 88 12.5 43 12.8 164 9.7 61 7.9 40 9.5 535 10.5
Suicidal ideation in previous two weeks
Not at all 885 74.4 510 71.8 237 70.1 1,268 74.7 592 75.2 311 72.5 3,803 73.8
Some days 200 16.8 129 18.2 70 20.7 305 18.0 148 18.8 87 20.3 939 18.2
More than half the days 51 4.3 33 4.6 10 3.0 63 3.7 20 2.5 16 3.7 193 3.7
Nearly every day 54 4.5 38 5.4 21 6.2 62 3.7 27 3.4 15 3.5 217 4.2
Alcohol dependencyd
Not alcohol dependent 936 79.1 553 78.4 262 77.7 1,345 79.7 629 80.5 363 85.6 4,088 79.9
Alcohol dependent 248 20.9 152 21.6 75 22.3 343 20.3 152 19.5 61 14.4 1,031 20.1
Ever taken recreational or illicit drugs
No 367 31.1 254 35.9 151 44.7 597 35.3 294 37.4 176 41.6 1,839 35.9
Yes 812 68.9 454 64.1 187 55.3 1,092 64.7 492 62.6 247 58.4 3,284 64.1
Illicit drugs used in previous yeare
Cannabis 609 51.7 326 46.0 131 38.8 797 47.2 333 42.5 192 45.4 2,388 46.6
Cocaine 192 16.3 98 13.9 39 11.5 222 13.2 123 15.6 40 9.5 714 14
Ecstasy pills 152 12.9 53 7.5 15 4.4 147 8.7 77 9.5 16 3.8 458 8.9
Ecstasy in the form of a crystal or powder 146 12.4 65 9.2 19 5.6 132 7.8 59 7.5 23 5.5 444 8.7
GHB or GBL 136 11.5 46 6.5 9 2.7 119 7.1 58 7.4 8 1.9 373 7.3
Crystal methamphetamine 80 6.8 43 6.1 16 4.7 129 7.6 29 3.7 13 3.1 310 6.1
Ever injected any drugsf
No, never 1,139 96.0 679 95.8 328 96.8 1,640 96.6 770 98.1 413 96.3 4,969 96.5
Yes 48 4.0 30 4.2 11 3.2 58 3.4 15 1.9 16 3.7 178 3.5

Abbreviations: GBL, gamma-Butyrolactone; GHB, Gamma-hydroxybutyrate

a The total counts for each characteristic do not always add up to the provincial totals because only participants with non-missing values were included. Missing values make up less than 3% of the totals

b Because someone knew or presumed the participant was attracted to men

c PHQ-4 measurement (13)

d CAGE 4-item Indicator (14)

e The denominators for the proportions of participants who used each substance are based on the number of participants who responded to the individual substance use questions. Total counts for each substance ranged from 5,113 to 5,121. The proportions for substances used do not add up to 100% as they were not mutually exclusive; participants could report the use of more than one substance

f Other than anabolic steroids or prescribed medicine